Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause.

Kohn OF. In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause. Ann Intern Med. 2021 05; 174(5):JC53.

View in: PubMed

collapse authors with profiles